Clinical Utility of Contezolid-Containing Regimens in 25 Cases of Linezolid-Intolerable Tuberculosis Patients

OBJECTIVE: Linezolid is increasingly used in the treatment of multidrug-resistant (MDR) M. tuberculosis (TB) with good efficacy; however, its clinical use is limited by intolerable adverse events (AEs). This usually results in dose adjustment or even discontinuation. Contezolid is a new oxazolidinon...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jun, Nie, Wenjuan, Ma, Liping, Li, Qiang, Geng, Ruixue, Shi, Wenhui, Chu, Naihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517683/
https://www.ncbi.nlm.nih.gov/pubmed/37745897
http://dx.doi.org/10.2147/IDR.S425743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517683/
https://www.ncbi.nlm.nih.gov/pubmed/37745897
http://dx.doi.org/10.2147/IDR.S425743

Ejemplares similares